Health care professionals should explore the use of glucagon-like peptide-1 receptor agonists (GLP1RAs) for cardiovascular risk reduction and their broader impacts on cardiometabolic health beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback